Anzalone Christopher Richard

EDGAR CIK 0001423029

Arrowhead Pharmaceuticals, Inc. - ARWR

CEO Director
Chief Executive Officer
Direct Buys
0
$0
0 Shares
Direct Sells
7
($3.34) M
-243,342 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
04/11/2025
04/11/2025
Sell
-50,800 @ $11.49
($583,692) 3,921,255 (-1.28%) Direct
04/10/2025
04/11/2025
Sell
-50,000 @ $10.87
($543,500) 3,972,055 (-1.24%) Direct
04/09/2025
04/11/2025
Sell
-40,322 @ $10.07
($406,145) 4,022,055 (-0.99%) Direct
03/13/2025
03/17/2025
Sell
-51,425 @ $15.07
($774,975) 4,062,377 (-1.25%) Direct
01/02/2025
10b5-1
01/06/2025
Sell
-11,520 @ $19.05
($219,456) 3,764,252 (-0.31%) Direct
12/23/2024
10b5-1
12/23/2024
Sell
-12,563 @ $19.59
($246,109) 3,775,772 (-0.33%) Direct
12/18/2024
10b5-1
12/20/2024
Sell
-26,712 @ $21.24
($567,486) 3,688,335 (-0.72%) Direct